Your browser doesn't support javascript.
loading
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng, Hailong; Huang, Yan; Xiao, Yazhi; Zhu, Zhenru; Shen, Mengying; Zhou, Peitao; Guo, Zeqin; Wang, Jian; Wang, Hui; Dai, Wencong; Zhang, Wanjun; Sun, Jingyuan; Cao, Chuanhui.
Afiliação
  • Sheng H; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Huang Y; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Xiao Y; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Zhu Z; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Shen M; Hepatology Unit and Department of Infectious Diseases, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Zhou P; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Guo Z; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Wang J; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Wang H; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Dai W; Hepatology Unit and Department of Infectious Diseases, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Zhang W; Department of Stomatology, No 2 Hospital of Baoding, Baoding, Hebei, China.
  • Sun J; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China.
  • Cao C; Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China huichuancao@163.com.
J Immunother Cancer ; 8(1)2020 05.
Article em En | MEDLINE | ID: mdl-32461345

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfóxidos / Radioimunoterapia / Carcinoma Hepatocelular / Quimiorradioterapia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfóxidos / Radioimunoterapia / Carcinoma Hepatocelular / Quimiorradioterapia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido